Non-Diabetic Weight Loss Injections: Your Questions Answered

Step 1: Understand what these medicines actually are (and who they're for)

Mounjaro and Wegovy were not developed as diabetes medicines repurposed for weight loss, they hold separate UK licences for weight management in their own right. Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist made by Eli Lilly; Wegovy (semaglutide) is a GLP-1 receptor agonist made by Novo Nordisk. Both slow the rate at which the stomach empties and signal fullness to the brain, which means most people naturally eat less without white-knuckling it.

The licensed eligibility for private treatment is an adult BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition, high blood pressure, high cholesterol, obstructive sleep apnoea, prediabetes and osteoarthritis all count. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. You can explore the broader range of weight loss injections available in the UK to see how the two medicines compare before deciding which to ask about.

One thing that surprises many people: Ozempic, which is also semaglutide, carries a UK licence for type 2 diabetes only, not weight management. The overlap between diabetes injections and weight loss causes a lot of understandable confusion, Ozempic and Wegovy are the same molecule but different licensed products. If you are researching whether a diabetic injection can help with weight loss, it is worth understanding that distinction clearly before drawing any conclusions. If a seller is offering Ozempic for weight loss, that is a red flag worth taking seriously.

Step 2: Get a clinical assessment, the legal and practical gateway

Because Mounjaro and Wegovy are prescription-only medicines, you cannot buy them the way you'd pick up a supplement. The only lawful route is a consultation followed by a prescriber's decision. That step protects you: some people have health conditions that make GLP-1 medicines unsuitable, including a history of pancreatitis, medullary thyroid carcinoma, or certain gastrointestinal conditions, and a prescriber needs to know about them.

We know the NHS route feels slow for many people right now. Waiting lists for specialist weight management services exist, and the phased NHS rollout of Mounjaro means most people without multiple serious comorbidities won't qualify for funded treatment for some time yet. Private treatment through a regulated pharmacy is the practical alternative, you can read more about the full range of weight loss treatment options and what each involves. At nume, a GPhC-registered Independent Prescriber reviews your consultation the same day, a named clinician reads your answers, not software. Our clinical team's approach is described on the clinical team page if you'd like to know more about who is reviewing your case.

It is also worth knowing that non-injection weight loss options now exist, the Wegovy tablet received MHRA approval in June 2026 as the UK's first oral GLP-1 medicine for weight management, which is useful to know if needles feel like a barrier.

Step 3: Know the safety picture before you start

The most common side effects with both medicines are gastrointestinal: nausea, loose stools, constipation, reflux and burping tend to cluster in the first few days after starting or after a dose increase, then ease. The NHS guidance on tirzepatide and its equivalent for semaglutide both describe these clearly and are worth reading before your first pen arrives.

There is one side effect that needs prompt attention. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as an infrequent but serious risk with GLP-1 medicines. Severe, persistent stomach pain that radiates toward the back (with or without vomiting) is a signal to stop the injection and seek urgent medical help the same day. Do not wait to see if it settles.

On contraception: if you are taking the oral contraceptive pill and starting Mounjaro, the MHRA advises adding a barrier method for the first four weeks of treatment and for four weeks after each dose increase, because slowed gastric emptying can reduce how reliably the pill is absorbed. There is no equivalent guidance for Wegovy at the time of writing. And if you are pregnant, breastfeeding, or actively trying to conceive, neither medicine is recommended, your prescriber will discuss timing and contraception with you. The NHS England guidance on weight management injections covers this in plain language.

Step 4: Think about whether private treatment is the right route for you

Private treatment costs more than a prescription charge, and it is right to weigh that honestly. Legitimate private prescriptions for these medicines include the clinical consultation, the prescription itself, delivery and ongoing clinical support, any quote that strips those out to show a lower headline figure is worth scrutinising. If you want to understand more about how a diabetic injection used for weight loss differs from a medicine licensed specifically for weight management, that context can help you ask sharper questions when comparing providers. Pages covering the reality behind cheap weight loss injection listings go into the detail of what those prices often miss.

Counterfeits are a real problem in this market. The MHRA has seized large quantities of fake weight loss pens sold online, some of which contained insulin rather than the stated medicine. Checking that any pharmacy you use appears on the GPhC register (verifiable at the GPhC pharmacy register) takes under a minute and matters. Any seller offering these medicines without a prescription is operating outside the law, full stop.

If you'd like a broader starting point before committing to anything, the weight loss overview page covers the full treatment landscape. Our frequently asked questions address many of the practical queries people have before their first consultation. And if something specific is on your mind that isn't covered there, our support team is available seven days a week.